Antenatal exposure to selective serotonin reuptake inhibitors and duration of gestation

Journal of Clinical Psychiatry

Volumn 74, Issue 7, 2013, Pages

  Andrade, Chittaranjan ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR;

ALCOHOL CONSUMPTION; ARTICLE; CESAREAN SECTION; CONFOUNDING VARIABLE; GESTATIONAL AGE; HIGH RISK PREGNANCY; HUMAN; MATERNAL AGE; NEWBORN DISEASE; PHYSICAL DISEASE; PREGNANT WOMAN; PREMATURE LABOR; PREMATURITY; PRENATAL EXPOSURE; PRESCRIPTION; PRIORITY JOURNAL; PUERPERAL DEPRESSION; SMOKING; SOCIAL STATUS; TREATMENT INDICATION;

EID: 84881017613     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.13f08617     Document Type: Article

References (25)

1. Chambers CD, Johnson KA, Dick LM, et al. Birth outcomes in pregnant women taking fluoxetine. N Engl J Med. 1996;335(14):1010-1015.
2. Ericson A, Kallén B, Wiholm B. Delivery outcome after the use of antidepressants in early pregnancy. Eur J Clin Pharmacol. 1999;55(7):503-508.
3. Simon GE, Cunningham ML, Davis RL. Outcomes of prenatal antidepressant exposure. Am J Psychiatry. 2002;159(12):2055-2061.
4. Wen SW, Yang Q, Garner P, et al. Selective serotonin reuptake inhibitors and adverse pregnancy outcomes. Am J Obstet Gynecol. 2006;194(4):961-966.
5. Sun R, Altshuler L, Hellemann G, et al. Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth. Am J Psychiatry. 2007;164(8):1206-1213.
6. Wisner KL, Sit DK, Hanusa BH, et al. Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes. Am J Psychiatry. 2009;166(5):557-566.
7. Lund N, Pedersen LH, Henriksen TB. Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes. Arch Pediatr Adolesc Med. 2009;163(10):949-954.
8. Roca A, Garcia Esteve L, Imaz ML, et al. Obstetrical and neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitors: the relevance of dose. J Affect Disord. 201-1;135(1-3):208-215.
9. Yonkers KA, Norwitz ER, Smith MV, et al. Depression and serotonin reuptake inhibitor treatment as risk factors for preterm birth. Epidemiology. 2012;23(5):677-685.
10. El Marroun H, Jaddoe \TW, Hudziak JJ, et al. Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes. Arch Gen Psychiatry. 2012;69(7):706-714.
11. Pastuszak A, Schick Boschetto B, Zuber C, et al. Pregnancy outcome following first trimester exposure to fluoxetine (Prozac). JAMA. 1993;269(17):2246-2248.
12. Nulman I, Rovet J, Stewart DE, et al. Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med. 1997;336(4):258-262.
13. Kuhn NA, Pastuszak A, Sage SR, et al. Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study. JAMA. 1998;279(8):609-610.
14. Malm H, Klaukka T, Neuvonen PJ. Risks associated with selective serotonin reuptake inhibitors in pregnancy. Obstet Gynecol. 2005;106(6):1289-1296.
15. Pearson KH, Nonacs RM, Viguera AC, et al. Birth outcomes following prenatal exposure to antidepressants. J Clin Psychiatry. 2007;68(8):1284-1289.
16. Toh S, Mitchell AA, Loulk C, et al. Antidepressant use during pregnancy and the risk of preterm delivery and fetal growth restriction. J Clin Psychopharmacol. 2009;29(6) :555-560.
17. Nordeng H, van Gelder MM, Spigset O, et al. Pregnancy outcome after exposure to antidepressants and the role of maternal depression: results from the Norwegian Mother and Child Cohort Study. J Clin Psychopharmacol. 2012;32(2):186-194.
18. Oberlander TF, Warburton W, Misri S, et al. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population based linked health data. Arch Gen Psychiatry. 2006;63(8):898-906.
19. Ross LE, Grigoriadis S, Mamisashvili L, et al. Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta analysis. JAMA Psychiatry 2013;70(4):436-443.
20. Spong CY. Defining "term" pregnancy: recommendations from the Defining "Term" Pregnancy Workgroup [published online ahead of print May 3,2013]. JAMA. 2013;1-2.
21. Oshiro BT, Henry E, Wilson J, et al; Women and Newborn Clinical Integration Program. Decreasing elective deliveries before 39-weeks of gestation in an integrated health care system. Obstet Gynecol. 2009;113(4):804-811.
22. Tita AT, Landon MB, Spong CY, et al. Eunice Kennedy Shriver NICHD Maternal Fetal Medicine Units Network. Timing of elective repeat cesarean delivery at term and neonatal outcomes. N Engl J Med. 2009;360(2): 111-120.
23. Tita AT, Lai Y, Landon MB, et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal Fetal Medicine Units Network (MFMU). Timing of elective repeat cesarean delivery at term and maternal perioperative outcomes. Obstet Gynecol. 201-1;1-17(2-pt 1):280-286.
24. MacDorman MF, Kirmeyer SE, Wilson EC. Fetal and perinatal mortality, United States, 2006. NatI Vital Stat Rep. 2012;61(1).
25. Glavind J, Kindberg S, Uldbjerg N, et al. Elective caesarean section at 38-weeks versus 39-weeks: neonatal and maternal outcomes in a randomised controlled trial [published online ahead of print May 20,2013]. BJOG.